SLE; Drug
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE (NCT04643067) | Kangpu Biopharmaceuticals, Ltd. | 2021-06-03 |
Track SLE; Drug automatically
Every clearance here is in the API, with alerts when new ones post.